Stock Message Board Recent Posts http://investorshangout.com/search?q=GLAXF&am...mp;yt0=Go!
Last Updated: 08/01/2014 03:50:30
Current Price and Quotes
Last Price 24.051
Previous Close 24.05 Open 24.21
Daily Range N/A - 24.61 52wk Range 23.93 - 28.56
Volume 1,713 Dividend N/A
Average Vol (3m) 3,966 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 43,899,000 42,964,000 42,563,000 44,452,000
Cost of Revenue 14,219,000 12,882,000 11,925,000 12,366,000
Gross Profit 29,680,000 30,082,000 30,638,000 32,087,000
Operating Expenses
Research and Development 6,498,000 6,468,000 6,248,000 6,978,000
Sales, General and Admin. 11,542,000 11,748,000 12,371,000 19,185,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 11,640,000 11,866,000 12,020,000 5,923,000
Income From Continuing Operations
Add'l Income/Expense Items 568,000 128,000 1,049,000 195,000
Earnings Before Interest and Tax 12,279,000 12,041,000 13,092,000 6,244,000
Interest Expense 1,270,000 1,313,000 1,242,000 1,301,000
Earnings Before Tax 11,009,000 10,728,000 11,850,000 4,943,000
Income Tax 1,688,000 3,124,000 3,450,000 2,042,000
Minority Interest 318,000 291,000 306,000 343,000
Equity Earnings Unconsolidated Subsidiary 71,000 47,000 23,000 127,000
Net Income Cont. Operations 9,075,000 7,360,000 8,117,000 2,685,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,003,000 7,313,000 8,094,000 2,558,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,003,000 7,313,000 8,094,000 2,558,000
Recent News
Jul 31, 2014 Global Parkinson's Disease Market 2014-2018: Key Vendors are Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva
Jul 31, 2014 Research and Markets: Global Parkinson's Disease Market 2014-2018: Key Vendors are Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva
Jul 29, 2014 GSK's Tanzeum(TM) is now available in pharmacies in the U.S.
Jul 28, 2014 MorphoSys AG Reports Results for the First Six Months of 2014
Jul 26, 2014 PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Johnson & Weaver, LLP Reminds Investors of Upcoming September 16, 2014 Deadline; Encourages Investors with Significant Losses to Contact the Firm
Jul 26, 2014 Discover how different regions approach and manage Market Access & HTA Assessments with Novartis, GSK, BMS, Gilead, Ministry of Health and more
Jul 24, 2014 FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States
Jul 24, 2014 Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma
Jul 23, 2014 INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Announced by Law Offices of Howard G. Smith
Jul 23, 2014 Ligand Partner GSK Announces Record Quarterly Promacta(TM)/Revolade(TM) Revenue of $92 Million
1
2
3
4
5
6
7
8
next >
GLAXF GlaxoSmithKline plc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GLAXF/quote
Stock Chart http://www.otcmarkets.com/stock/GLAXF/chart
Company Info http://www.otcmarkets.com/stock/GLAXF/company-info
Recent News http://www.otcmarkets.com/stock/GLAXF/news
Financials http://www.otcmarkets.com/stock/GLAXF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GLAXF/filings
Short Sales http://www.otcmarkets.com/stock/GLAXF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GLAXF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GLAXF/research
Summary http://finance.yahoo.com/q?s=GLAXF
Historical Prices http://finance.yahoo.com/q/hp?s=GLAXF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GLAXF
Basic Chart http://finance.yahoo.com/q/bc?s=GLAXF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GLAXF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GLAXF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GLAXF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GLAXF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GLAXF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GLAXF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GLAXF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GLAXF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GLAXF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GLAXF
Balance Sheet http://finance.yahoo.com/q/bs?s=GLAXF
Cash Flow http://finance.yahoo.com/q/cf?s=GLAXF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GLAXF
Market Watch http://www.marketwatch.com/investing/stock/GLAXF
Bloomberg http://www.bloomberg.com/quote/GLAXF:US
Morningstar http://quotes.morningstar.com/stock/s?t=GLAXF
Bussinessweek http://investing.businessweek.com/research/st...cker=GLAXF
Barchart http://www.barchart.com/quotes/stocks/GLAXF
OTC Short Report http://otcshortreport.com/index.php?index=GLAXF
Investopedia http://www.investopedia.com/markets/stocks/GLAXF/?wa=0